Category: Colombia
Preprint: MU B.1.621 the most resistant variant to convalescent and vaccinated sera to date
Here, we demonstrate that the Mu variant is highly resistant to sera from COVID-19 convalescents and BNT162b2-vaccinated individuals. More...
WHO designates B.1.621 as a variant of interest named “Mu”
Based on the latest round of assessments, B.1.621 was classified as a VOI on 30 August 2021 and given the WHO label “Mu”. More...
USA: B.1.621 now at 10% of Covid-19 sequences in South Florida
Carlos Migoya, CEO of Jackson Health, revealed that now 10% of COVID-positive patients whose results are being sequenced at the University of Miami’s pathology lab have a strain [B.1.621] that originated out of Colombia. More...
Preprint: Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2
In this study, we reported the emergence and spread of the novel B.1.621 lineage of SARS-CoV-2, a new VOI with the insertion 146N and several amino acid substitutions in the Spike protein (T95I,Y144T, Y145S, R346K, E484K, N501Y and P681H). More...
Belgium: 7 fully vaccinated care home residents die after contracting B.1.621 Mu variant first found in Colombia
During the past two weeks, 7 residents of a care home near Zaventem in Belgium have died after having contracted the B.1.621 variant of coronavirus first identified in Colombia, South America. More...
Preprint: The emergence of Sars-CoV-2 coronavirus variant Lambda C.37 in South America
We report the emergence of a novel lineage of SARS-CoV-2 in South America, termed C.37. More...
Countries with increasing coronavirus rates as of mid June 2021
There are still a large number of countries across the globe where Sars-CoV-2 is increasing as of June 16th 2021 – Great Britain, Colombia, Mongolia, Kuwait, Brazil, South Africa, Russia, Oman, Panama, Tunisia, and Afghanistan have all seen recent surges. More...
Colombia: novel highly divergent coronavirus SARS-CoV-2 lineage with the Spike substitutions L249S and E484K, assigned to the B.1.111 lineage
Here we report a novel and highly divergent lineage with 21 characteristic mutations, including 10 non-synonymous, 8 synonymous and 3 mutations in non-coding regions (5’and 3’ UTR and intergenic region). More...